QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study 期刊论文 JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 卷号: 6, 期号: 1 作者:  Hu, Peng;  Shang, Jia;  Zhang, Wenhong;  Gong, Guozhong;  Li, Yongguo 收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05 Antiviral therapy  Peg-interferon  Nucleos(t)ide treated  Chronic hepatitis B   Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment 期刊论文 NATURE COMMUNICATIONS, 2017, 卷号: 8 作者:  Gu, Yanyun;  Wang, Xiaokai;  Li, Junhua;  Zhang, Yifei;  Zhong, Huanzi 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05 Increased and sustained HBsAg loss in HBeAg positive CHB patients switched from NUC to Peg-IFN alfa-2a: A randomised open label trial (NEW SWITCH study) 会议论文 作者:  Hu, Peng;  Dou, Xiaoguang;  Jiang, Jian-ning;  Jia, Shang;  Zhang, Wen Hong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/06 PREDICTIVE VALUE OF BASELINE AND ON-TREATMENT qHBsAg LEVEL IN HBeAg POSITIVE CHB PATIENTS WHO SWITCHED FROM NUCS TO PEGYLATED INTERFERON A-2A: A FURTHER ANALYSIS FROM NEW SWITCH STUDY 会议论文 作者:  Hu, P.;  Shang, J.;  Zhang, W.;  Gong, G.;  Li, Yongguo 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/19 A multi-center randomized study on the efficacy and safety of switching to peginterferon alpha-2a (40KD) for 48 or 96 weeks in HBeAg positive CHB patients with a prior NUC history for 1 to 3 years: an interim analysis of NEW SWITCH study 会议论文 作者:  Hu, Peng;  Jia, Shang;  Zhang, Wen Hong;  Gong, Guozhong;  Li, Yongguo 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19